Anti-Xa activity : low molecular weight heparin - LMWH - plasma

Back to the list
Eurofins Biomnis code

XA

Synonyms
  • Anti-Xa - LMWH
  • Anti-Xa activity - low molecular weight heparin
  • Measurement of anti-Xa activity - low molecular weight heparin
Specialty

Haematology


Clinical significance

Heparin is prescribed to prevent or correct thrombosis and embolization. For low molecular weight heparin therapy, the sample should be taken 3 to 4 hours after injection.

Preanalytics
  • A tube specifically for this analysis : No
Further information

Enclose the specific clinical information form (R5-INTGB : Haemostasis)
Sample to be frozen within 1 hour. Home sampling is not advisable.
ALWAYS specify the current anticoagulant treatment (dosage) and the injection and sampling times
Sample 3 to 4 hours after subcutaneous injection of Lovenox®, Fragmine®, Fraxiparine® , Clivarine® or 4 to 6 hours after subcutaneous injection of Innohep® or Fraxodi®
It is advisable to send us a frozen and centrifuged citrate sample in compliance with the GFHT pre-analytical recommendations.


Methodology

Chromogenic method

Turnaround time

1 day


Testing Laboratory

Biomnis Ivry